Drug Shortage Report for RELEFACT TRH INJECTION 200MCG/ML
| Report ID | 949 |
| Drug Identification Number | 02224615 |
| Brand name | RELEFACT TRH INJECTION 200MCG/ML |
| Common or Proper name | Protirelin Injection i.v. |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | Protirelin |
| Strength(s) | 0.2 mg/mL |
| Dosage form(s) | Liquid |
| Route of administration | I.V. injection |
| Packaging size | 1 mL |
| Anatomical Therapeutical Chemical (ATC) code | V04CJ |
| Anatomical Therapeutical Chemical (ATC) description | OTHER DIAGNOSTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2016-04-15 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | [email protected] Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-03-13 | French | Compare |
| v1 | 2017-03-13 | English | Compare |
Showing 1 to 2 of 2